We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

47 hedge funds and large institutions have $41.5M invested in Pyxis Oncology in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

57% more capital invested

Capital invested by funds: $26.5M → $41.5M (+$15M)

52% more funds holding

Funds holding: 31 → 47 (+16)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

28.3% less ownership

Funds ownership: 56.3% → 28% (-28%)

Holders
47
Holders Change
+16
Holders Change %
+51.61%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
8
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$503K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$289K
3
HIS
Harvest Investment Services
Illinois
+$182K
4
Jane Street
Jane Street
New York
+$151K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$145K

Top Sellers

1
BI
BVF Inc
California
-$3.94M
2
Citadel Advisors
Citadel Advisors
Florida
-$3.07M
3
NM
Newtyn Management
New York
-$2.01M
4
TCM
Tang Capital Management
California
-$1.98M
5
Barclays
Barclays
United Kingdom
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
1
Laurion Capital Management
New York
$12.7M – – –
TCM
2
Tang Capital Management
California
$9.95M -$1.98M -989,038 -28%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.26M +$289K +144,722 +16%
TCM
4
Tekla Capital Management
Massachusetts
$2.84M – – –
HA
5
HHLR Advisors
Cayman Islands
$2.13M -$467K -233,714 -31%
CAM
6
Cormorant Asset Management
Massachusetts
$1.09M -$792K -396,317 -59%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$1.01M +$503K +251,800 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$960K +$70.7K +35,417 +17%
BlackRock
9
BlackRock
New York
$851K +$1.91K +956 +0.5%
BCM
10
Bridgeway Capital Management
Texas
$683K – – –
Morgan Stanley
11
Morgan Stanley
New York
$676K +$124K +62,157 +58%
Barclays
12
Barclays
United Kingdom
$474K -$1.66M -829,828 -88%
Renaissance Technologies
13
Renaissance Technologies
New York
$378K +$21.2K +10,600 +13%
HIS
14
Harvest Investment Services
Illinois
$365K +$182K +91,047 New
Jane Street
15
Jane Street
New York
$302K +$151K +75,430 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$291K +$145K +72,545 New
ECM
17
ExodusPoint Capital Management
New York
$281K +$140K +70,000 New
HF
18
HRT Financial
New York
$279K +$139K +69,782 New
State Street
19
State Street
Massachusetts
$250K – – –
UOC
20
University of Chicago
Illinois
$195K – – –
Squarepoint
21
Squarepoint
New York
$152K +$75.8K +37,945 New
Goldman Sachs
22
Goldman Sachs
New York
$142K +$70.8K +35,424 New
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$130K -$78.3K -39,196 -55%
Northern Trust
24
Northern Trust
Illinois
$126K +$10.2K +5,109 +19%
Citadel Advisors
25
Citadel Advisors
Florida
$109K -$3.07M -1,535,669 -98%
1
2 3

PYXS Hedge Fund Activity: Q1 2023 in Review

47 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q1 2023, worth a combined $41.5M — up 57% from $26.5M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PYXS positions and 8 closed out — a net gain of 16 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $503K. The largest seller was BVF Inc, exiting entirely with an estimated $3.94M sold.

  • 47 institutional investors held Pyxis Oncology (PYXS) as of Q1 2023, up from 31 in Q4 2022.
  • Funds reported $41.5M of Pyxis Oncology stock for Q1 2023, up 57% quarter-over-quarter.
  • 24 funds opened new Pyxis Oncology positions in Q1 2023 and 8 closed out, a net change of +16 holders.
  • The largest Pyxis Oncology buyer in Q1 2023 was Point72 Asset Management, an estimated $503K added.
  • The largest Pyxis Oncology seller in Q1 2023 was BVF Inc, an estimated $3.94M sold.

Based on aggregated 13F filings for Q1 2023.